Company ProfileWe are a biotechnology company focused on immunotherapy and leveraging a unique high-dimensional immune profiling Platform.A spin-off from the lab of Dr Evan Newell at Singapore Immunology Network, A*STAR, immunoSCAPE employs cutting-edge technologies and mass cytometry to measure alterations of immune cells, and in particular T cell specificity, for biomarker and target identification.immunoSCAPE offers service to partners looking to optimize their early R&D phase pipeline in oncology and infectious diseases.